Community Bank’s Avidity Biosciences RNAM Stock Holding History

Community Bank’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8	Closed	–	–	652
2022 Q3	$0	Buy	+8	New	+$153	﹤0.01%	685

Other funds holding RNAM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Community Bank's RNAM Position: Q4 2022 in Review

Community Bank sold out of Avidity Biosciences (RNAM) in Q4 2022, closing a stake of 8 shares.

Community Bank first reported a position in RNAM in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 148 funds tracked by Wall St. Rank hold RNAM as of Q4 2022.

Community Bank reported no remaining Avidity Biosciences position as of Q4 2022 after selling out during the quarter.
Community Bank sold 8 Avidity Biosciences shares in Q4 2022.
Community Bank first reported a position in Avidity Biosciences in Q3 2022 and held it in 1 quarter.
Community Bank's Avidity Biosciences position peaked at $0 in Q3 2022.
148 funds tracked by Wall St. Rank held Avidity Biosciences as of Q4 2022.

Based on Community Bank's 13F filing for Q4 2022, filed 31 Jan 2023.